Solara Active Pharma Sciences has reported total income of Rs. 347.27 crores during the period ended September 30, 2024
Silica is a proven and highly effective anti-caking agent that has been used for decades
ActivShield technology is a portable, novel sterilization modality that does not require conventional infrastructure
Product basket comprises 2,047 medicines and 300 surgical devices covering all major therapeutic groups
Financing includes new funding from leading global organizations Eli Lilly and Company and EDBI
Infant Mortality Rate in Bihar came down from 42 to 27 in 2020, and in Jharkhand, from 34 to 25 in 2020
The proceeds from its fresh issuance to the extent of Rs 107 crore will be utilized for funding the capital expenditure requirements
JB’s absolute Scope1 & Scope2 emissions reduced by 13.9 % in the last financial year, despite turnover increasing by 11%
Diltiazem Hydrochloride Extended-Release Capsules USP are indicated for the treatment of hypertension
Subscribe To Our Newsletter & Stay Updated
